Literature DB >> 8567056

Serum fatty acids and blood pressure.

J A Simon1, J Fong, J T Bernert.   

Abstract

To examine the relation between serum fatty acids and blood pressure, we conducted a cross-sectional study of 156 men who were enrolled in the Multiple Risk Factor Intervention Trial. After confirming the stability of the stored serum samples, we measured serum fatty acid levels by gas-liquid chromatography and examined their association with blood pressure. Using stepwise linear regression, we determined that each SD increase (1.9%) in the serum level of cholesterol ester palmitoleic acid (16:1) was associated with a systolic pressure increase of 3.3 mm Hg (95% confidence interval, 0.9 to 5.6 mm Hg) and each SD increase (0.1%) in phospholipid omega 9 eicosatrienoic acid (20:3) was associated with a diastolic pressure increase of 1.7 mm Hg (95% confidence interval, 0.5 to 2.9 mm Hg). Serum level of cholesterol ester steric acid (18:0) was inversely associated with diastolic pressure: each SD increase (0.2%) was associated with a decrease of 1.4 mm Hg (95% confidence interval, -2.5 to -0.2 mm Hg). In multivariate models that included dietary fat intake, cholesterol ester dihomogammalinolenic acid (20:3) was also associated with diastolic pressure: each SD increase (0.16%) was associated with an increase of 1.2 mm Hg (95% confidence interval, 0.1 to 2.4 mm Hg). Our results indicate that three nonessential fatty acids--stearic acid, palmitoleic acid, and omega 9 eicosatrienoic acid, and one essential fatty acid--dihomogammalinolenic acid, are independent correlates of blood pressure among middle-aged American men at high risk of coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8567056     DOI: 10.1161/01.hyp.27.2.303

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  16 in total

1.  Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study.

Authors:  Dariush Mozaffarian; Haiming Cao; Irena B King; Rozenn N Lemaitre; Xiaoling Song; David S Siscovick; Gökhan S Hotamisligil
Journal:  Ann Intern Med       Date:  2010-12-21       Impact factor: 25.391

2.  Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.

Authors:  Dariush Mozaffarian; Haiming Cao; Irena B King; Rozenn N Lemaitre; Xiaoling Song; David S Siscovick; Gökhan S Hotamisligil
Journal:  Am J Clin Nutr       Date:  2010-10-13       Impact factor: 7.045

3.  Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosis.

Authors:  Marcia L E MacDonald; Miranda van Eck; Reeni B Hildebrand; Brian W C Wong; Nagat Bissada; Piers Ruddle; Anatol Kontush; Hala Hussein; Mahmoud A Pouladi; M John Chapman; Catherine Fievet; Theo J C van Berkel; Bart Staels; Bruce M McManus; Michael R Hayden
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-12-18       Impact factor: 8.311

4.  Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice.

Authors:  Marcia L E MacDonald; Roshni R Singaraja; Nagat Bissada; Piers Ruddle; Russell Watts; Joanna M Karasinska; William T Gibson; Catherine Fievet; Jean E Vance; Bart Staels; Michael R Hayden
Journal:  J Lipid Res       Date:  2007-10-24       Impact factor: 5.922

5.  Low levels of linoleic acid and α-linolenic acid and high levels of arachidonic acid in plasma phospholipids are associated with hypertension.

Authors:  Ikuyo Tsukamoto; Shiori Sugawara
Journal:  Biomed Rep       Date:  2017-11-08

Review 6.  Dietary stearic acid and risk of cardiovascular disease: intake, sources, digestion, and absorption.

Authors:  Penny M Kris-Etherton; Amy E Griel; Tricia L Psota; Sarah K Gebauer; Jun Zhang; Terry D Etherton
Journal:  Lipids       Date:  2005-12       Impact factor: 1.880

7.  Castration modifies aortic vasoreactivity and serum fatty acids in a sucrose-fed rat model of metabolic syndrome.

Authors:  Israel Perez; Mohammed El Hafidi; Karla Carvajal; Guadalupe Baños
Journal:  Heart Vessels       Date:  2009-04-01       Impact factor: 2.037

8.  The role of serum monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs) in cardiovascular disease risk.

Authors:  Jasmin Kharazmi-Khorassani; Roshanak Ghafarian Zirak; Hamideh Ghazizadeh; Reza Zare-Feyzabadi; Sara Kharazmi-Khorassani; Sharzad Naji-Reihani-Garmroudi; Elham Kazemi; Habibollah Esmaily; Ali Javan-Doust; Hamed Banpour; Maryam Mohammadi-Bajgiran; Mohhamad Reza Besharatlou; Gordon A Ferns; Mohammad Hashemi; Majid Ghayour-Mobarhan
Journal:  Acta Biomed       Date:  2021-05-12

9.  Plasma phospholipid fatty acid composition and estimated desaturase activity in heart failure patients with metabolic syndrome.

Authors:  Seungmin Lee; Hyun Ju Do; Seok-Min Kang; Ji Hyung Chung; Eunju Park; Min-Jeong Shin
Journal:  J Clin Biochem Nutr       Date:  2012-07-06       Impact factor: 3.114

10.  Chocolate and prevention of cardiovascular disease: a systematic review.

Authors:  Eric L Ding; Susan M Hutfless; Xin Ding; Saket Girotra
Journal:  Nutr Metab (Lond)       Date:  2006-01-03       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.